Solara Active Pharma Sciences Limited has informed the Exchange regarding interalia to consider and approve the audited Standalone and Consolidated Financial Results for the year ended March 31 2026 and unaudited Financial Results for the quarter ended March 31 2026 alongwith the Auditors report for the said period.